Found is not affiliated with or endorsed by Novo Nordisk, the manufacturer of Wegovy, Ozempic, Saxenda, and other GLP-1 medications
The NRAS gene encodes the N-ras protein (227)
Kokkorakis M, Chakhtoura M, Rhayem C et al (2025) Emerging pharmacotherapies for obesity: a systematic review
Weight loss accounts for the remaining benefit, meaning patients experience meaningful blood pressure improvement even if their initial weight loss plateaus, though maximum benefit typically emerges after 8-12 weeks of consistent therapy
That is a 31% reduction in TSH in under two months
Youll likely need to monitor more frequently and adjust other medications with your healthcare providers guidance.